Lab Features - Hypo, Hyper and Pseudohypoparathyroidism

Laboratory Features of Hypoparathyroidism

Primary Biochemical Profile

• The fundamental biochemical hallmark of hypoparathyroidism is the presence of hypocalcemia paired with hyperphosphatemia.
• The total serum calcium concentration is characteristically low, frequently measuring between 5 to 7 mg/dL.
• Blood levels of ionized calcium (the biologically active fraction, normally representing approximately 45% of total calcium) accurately reflect physiological deficiency and are consistently subnormal.
• The serum phosphorus level is reciprocally elevated, typically ranging from 7 to 12 mg/dL.
• This hyperphosphatemia occurs because the normal phosphaturic action of parathyroid hormone (PTH) on the proximal renal tubules is absent, leading to increased tubular reabsorption of filtered phosphate.
• Serum levels of intact PTH are inappropriately low or undetectable relative to the prevailing hypocalcemia when measured by sensitive immunometric assays.
• In certain dyshormonogenetic variants involving mutations in the signal peptide of PTH, the measured level of PTH may paradoxically appear normal or even high depending on the exact specificity of the immunoassay used, though the hormone is biologically inactive.

Additional Metabolites and Organ-Specific Tests

• Serum levels of 1,25-dihydroxyvitamin D3 (calcitriol) are typically low, because PTH is an absolute requirement for the stimulation of the renal 1-alpha-hydroxylase enzyme.
• Conversely, serum 25-hydroxyvitamin D (calcidiol) levels remain within the normal range.
• The serum level of alkaline phosphatase is generally normal or low, which is a key feature distinguishing hypoparathyroidism from rachitic or osteomalacic conditions where alkaline phosphatase is markedly elevated.
• Serum magnesium levels are typically normal. However, evaluating magnesium is critical because severe hypomagnesemia or hypermagnesemia can inhibit PTH secretion and cause a functional state of hypoparathyroidism.
• In acquired hypoparathyroidism associated with autoimmune polyendocrinopathy syndrome type 1 (APS1 or APECED), severe and recalcitrant hypomagnesemia is common.
• Urinary calcium excretion is typically low in classic forms of hypoparathyroidism due to the decreased filtered load of calcium.
• In contrast, in autosomal dominant hypocalcemia type 1 (caused by activating, gain-of-function mutations in the calcium-sensing receptor, CaSR), patients exhibit relative hypercalciuria despite their hypocalcemia and low PTH levels, predisposing them to nephrocalcinosis.
• Autoantibody testing may reveal specific markers in autoimmune hypoparathyroidism, including autoantibodies to NACHT leucine-rich repeat protein 5 (NALP5) and activating autoantibodies directed against the extracellular domain of the CaSR.
• An electrocardiogram (ECG) consistently reveals a prolongation of the QT interval, which normalizes once the hypocalcemia is corrected.

Laboratory Features of Pseudohypoparathyroidism (PHP)

Primary Biochemical Profile

• Patients with pseudohypoparathyroidism typically present with classic hypocalcemia and hyperphosphatemia, identical to the mineral profile seen in true hypoparathyroidism.
• This specific calcium and phosphate derangement is driven by a failure of the proximal renal tubular cells to respond to PTH, leading to decreased renal calcium reabsorption and exaggerated renal phosphate reabsorption.
• In stark contrast to true hypoparathyroidism, serum levels of immunoreactive PTH are markedly elevated.
• The elevated PTH occurs because the parathyroid glands are normal or hyperplastic and continuously secrete hormone in response to chronic hypocalcemia, but the target organs remain completely resistant to the hormone's biological effects.
• Serum calcidiol values are normal, whereas calcitriol levels are often inappropriately low for the degree of hypocalcemia, reflecting the resistance of the renal 1-alpha-hydroxylase enzyme to PTH stimulation.

Dynamic Testing (Ellsworth-Howard Test)

• The Ellsworth-Howard test involves the intravenous administration of exogenous synthetic human PTH (such as the 1-34 fragment, teriparatide acetate) to definitively assess renal responsiveness.
• In a healthy subject or a patient with primary hypoparathyroidism, this exogenous PTH causes urinary cyclic AMP (cAMP) excretion to increase 10- to 20-fold, accompanied by a severalfold increase in urinary phosphate excretion.
• In patients with classic PHP (types 1A and 1B), there is a blunted, subnormal response, characterized by a less than threefold increase in urinary cAMP and a failure to appropriately increase urinary phosphate excretion.

Subtype-Specific Laboratory Findings

• PHP Type 1A: Laboratory evaluation demonstrates hypocalcemia, hyperphosphatemia, high PTH, and blunted urinary cAMP and phosphate responses to exogenous PTH. Crucially, these patients exhibit subnormal Gs-alpha protein activity in their erythrocytes. Because resistance affects multiple G-protein-coupled receptors, basal TSH may be elevated (mild hypothyroidism) alongside potential resistance to gonadotropins and growth hormone-releasing hormone.
• PHP Type 1B: Features the same core mineral abnormalities (hypocalcemia, hyperphosphatemia, elevated PTH) and the same blunted urinary cAMP/phosphate responses to exogenous PTH as Type 1A. However, erythrocyte Gs-alpha activity is completely normal. The hormonal resistance is highly tissue-specific, primarily isolated to the proximal renal tubules.
• PHP Type 1C: Presents with hypocalcemia, hyperphosphatemia, elevated PTH, and blunted urinary cAMP and phosphate responses to exogenous PTH. Similar to Type 1B, erythrocyte Gs-alpha activity is normal, but the clinical phenotype includes Albright hereditary osteodystrophy.
• PHP Type 2: Characterized by hypocalcemia, hyperphosphatemia, and elevated serum PTH. Uniquely, the administration of exogenous PTH produces a normal increase in urinary cAMP excretion but fails to increase urinary phosphate excretion. This indicates a post-receptor defect in the intracellular signaling pathway distal to adenylyl cyclase generation, and erythrocyte Gs-alpha activity is normal.
• Pseudopseudohypoparathyroidism (PPHP): Patients possess the physical phenotype of Albright hereditary osteodystrophy but maintain completely normal serum calcium and phosphorus levels. Serum PTH levels are normal or only slightly elevated. Erythrocyte Gs-alpha activity is decreased, but both urinary cAMP and phosphate responses to exogenous PTH remain completely intact.

Laboratory Features of Hyperparathyroidism

Primary Hyperparathyroidism Profile

• The primary laboratory hallmark of primary hyperparathyroidism is elevated serum calcium (hypercalcemia) paired with a reduced serum phosphorus level (hypophosphatemia).
• Total serum calcium levels are often significantly elevated, frequently exceeding 12 mg/dL in children with solitary adenomas, and can reach extreme values ranging from 15 to 30 mg/dL in infants with severe neonatal parathyroid hyperplasia.
• Ionized calcium levels are consistently increased, which provides diagnostic confirmation even if total serum calcium is only borderline elevated.
• The serum phosphorus level is characteristically reduced to approximately 3 mg/dL or less due to the potent, uninhibited phosphaturic effect of excessive PTH on the proximal tubule.
• Serum levels of intact PTH are elevated, or they may fall within the upper limits of the normal range. A "normal" PTH value in the face of hypercalcemia is highly abnormal and diagnostically significant, because functioning physiological feedback should completely suppress PTH secretion during hypercalcemia.
• Serum levels of calcitriol (1,25-dihydroxyvitamin D3) are typically increased due to the direct stimulatory effect of elevated PTH on the renal 1-alpha-hydroxylase enzyme, while calcidiol (25-hydroxyvitamin D) levels generally remain normal.

Additional Metabolites and Urine Studies

• Patients typically exhibit hypercalciuria (increased urinary calcium excretion). While PTH acts to reabsorb calcium in the distal tubule, the sheer magnitude of the filtered calcium load overwhelmingly exceeds this reabsorptive capacity.
• The presence of hypercalciuria is an essential laboratory feature to differentiate primary hyperparathyroidism from familial hypocalciuric hypercalcemia (FHH), a condition where urinary calcium excretion is paradoxically extremely low (calcium-to-creatinine clearance ratio <0.01) despite hypercalcemia.
• Serum levels of magnesium are frequently low, while serum pH, carbon dioxide, and sodium concentrations may be elevated alongside decreased serum chloride.
• Serum levels of alkaline phosphatase are often elevated in patients with significant skeletal involvement (osteitis fibrosa cystica), reflecting highly increased osteoblastic activity attempting to repair the bone resorbed by excess PTH. Other specific markers of bone turnover, such as osteocalcin and N-terminal telopeptides, are also elevated.
• In infants with diffuse parathyroid hyperplasia, alkaline phosphatase levels may paradoxically remain normal despite the presence of extensive bone involvement.
• Unlike hypercalcemia of malignancy, serum concentrations of parathyroid hormone-related peptide (PTHrP) remain normal in primary hyperparathyroidism, which is a critical differential parameter.
• The electrocardiogram (ECG) typically reveals a shortened QT interval resulting from the accelerated rate of cardiac repolarization caused by the hypercalcemia. Additional ECG findings can include a prolonged PR interval, widened QRS complex, bradycardia, and first-degree atrioventricular block.

Secondary and Tertiary Hyperparathyroidism Profiles

• Secondary Hyperparathyroidism: This condition represents an appropriate, compensatory hypersecretion of PTH in response to chronic hypocalcemia or calcitriol deficiency.
• In cases caused by chronic renal failure, laboratory studies reveal high PTH, normal or low serum calcium, and distinctly elevated serum phosphate (which occurs once the glomerular filtration rate falls below 20-30 mL/min/1.73 m2). Serum calcitriol levels are inappropriately low.
• In cases caused by nutritional vitamin D deficiency or malabsorption, laboratory tests demonstrate high PTH, normal or low serum calcium, low serum phosphate, low serum calcidiol, and elevated alkaline phosphatase.
• Tertiary Hyperparathyroidism: This state develops when prolonged secondary hyperparathyroidism (most commonly in chronic renal failure) leads to autonomous parathyroid hyperfunction.
• Laboratory features of tertiary hyperparathyroidism show a shift from normocalcemia to overt hypercalcemia, occurring alongside hyperphosphatemia, profoundly elevated intact PTH, and signs of severe renal osteodystrophy.